Dagohoy CG - Search Results

1

Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control study.

Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Hassan MM, et al. Among authors: dagohoy cg. Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):959-65. doi: 10.1158/1055-9965.EPI-07-0750. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18398037

2

Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study.

Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Hassan MM, et al. Among authors: dagohoy cg. Int J Cancer. 2008 Aug 15;123(4):867-73. doi: 10.1002/ijc.23529. Int J Cancer. 2008. PMID: 18491401 Free article.

3

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. Yao JC, et al. J Clin Oncol. 2008 Jun 20;26(18):3063-72. doi: 10.1200/JCO.2007.15.4377. J Clin Oncol. 2008. PMID: 18565894 Review.

4

Rational Clinical Experiment: Assessing Prior Probability and Its Impact on the Success of Phase II Clinical Trials.

Halperin DM, Lee JJ, Dagohoy CG, Yao JC. Halperin DM, et al. Among authors: dagohoy cg. J Clin Oncol. 2015 Sep 10;33(26):2914-9. doi: 10.1200/JCO.2015.61.4362. Epub 2015 Aug 10. J Clin Oncol. 2015. PMID: 26261263 Free PMC article.

5

A Phase II Trial of Ziv-Aflibercept in Patients With Advanced Pancreatic Neuroendocrine Tumors.

Halperin DM, Lee JJ, Ng CS, Strosberg JR, Estrella JS, Dagohoy CG, Dasari A, Yao JC. Halperin DM, et al. Among authors: dagohoy cg. Pancreas. 2019 Mar;48(3):381-386. doi: 10.1097/MPA.0000000000001258. Pancreas. 2019. PMID: 30768575 Free PMC article. Clinical Trial.

6

Fluorouracil, Doxorubicin with Streptozocin and Subsequent Therapies in Pancreatic Neuroendocrine Tumors.

Rogers JE, Lam M, Halperin DM, Dagohoy CG, Yao JC, Dasari A. Rogers JE, et al. Among authors: dagohoy cg. Neuroendocrinology. 2022;112(1):34-42. doi: 10.1159/000514339. Epub 2021 Jan 12. Neuroendocrinology. 2022. PMID: 33434908 Free PMC article.

7

Population-based study of islet cell carcinoma.

Yao JC, Eisner MP, Leary C, Dagohoy C, Phan A, Rashid A, Hassan M, Evans DB. Yao JC, et al. Ann Surg Oncol. 2007 Dec;14(12):3492-500. doi: 10.1245/s10434-007-9566-6. Epub 2007 Sep 26. Ann Surg Oncol. 2007. PMID: 17896148 Free PMC article.

8

Perfusion computed tomography as functional biomarker in randomized run-in study of bevacizumab and everolimus in well-differentiated neuroendocrine tumors.

Yao JC, Phan AT, Hess K, Fogelman D, Jacobs C, Dagohoy C, Leary C, Xie K, Ng CS. Yao JC, et al. Pancreas. 2015 Mar;44(2):190-7. doi: 10.1097/MPA.0000000000000255. Pancreas. 2015. PMID: 25426617 Free PMC article. Clinical Trial.

9

Improving the success rate of gluteal intramuscular injections.

Boyd AE, DeFord LL, Mares JE, Leary CC, Garris JL, Dagohoy CG, Boving VG, Brook JP, Phan A, Yao JC. Boyd AE, et al. Among authors: dagohoy cg. Pancreas. 2013 Jul;42(5):878-82. doi: 10.1097/MPA.0b013e318279d552. Pancreas. 2013. PMID: 23508015

10

Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review Study.

Kulke MH, Benson AB, Dasari A, Huynh L, Cai B, Totev T, Roesner N, Duh MS, Neary MP, Maurer VE, Shih BE, Dagohoy CG, Chan J, Bergsland EK. Kulke MH, et al. Among authors: dagohoy cg. Oncologist. 2019 Aug;24(8):1056-1065. doi: 10.1634/theoncologist.2018-0519. Epub 2019 Jan 3. Oncologist. 2019. PMID: 30606883 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page